Peter Fellner

Peter has previously served on the Boards of a wide range of life science companies, including as Chairman of the MedTech company Consort Medical plc until April 2019, Chairman of Vernalis plc until October 2018, Chairman of Ablynx NV from November 2013 until January 2018, Vice-Chairman of Astex Pharmaceuticals Inc. until its sale to Otsuka in 2013, Chairman of Optos plc from 2000 until its acquisition by Nikon Corporation in 2015, Director of the global biopharmaceutical company UCB SA from 2005 to 2014 and Chairman of Acambis plc from 2006 until its acquisition by Sanofi in 2008.

He was Chairman of Celltech Group plc until its acquisition by UCB in 2004, having been CEO from 1990. Before joining Celltech he was CEO of Roche UK from 1986 to 1990. He served as a member of the Medical Research Council from 2000 to 2007.